Abstract:Background: Ventricular septal defect (VSD) is the most common congenital cardiac malformation, accounting for approximately 30% of congenital heart defects. Conventional surgical repair using cardiopulmonary bypass is invasive and associated with morbidities and prolonged hospital stay. With the advent of interventional approaches and availability of different occluding devices, the technique of perventricular device closure is evolving and being implemented successfully in larger groups of patients. We present herein, our initial experience of perventricular device closure for the ventricular septal defects in children to assess risks and benefits. Methods: From March, 2023 to February, 2024, we have performed perventricular closure of ventricular septal defects in 13 children, under guidance of transesophageal echocardiography without cardiopulmonary bypass support. The median age at operation was 2 year (range 1.3-10 years) with the median body weight 11 kg (range 8.7-16.6 kg). Sixty-nine percent were males. The ventricular septal defect sizes ranged from 2.7 to 6 mm (mean 4.7 mm). Seven defects were perimembranous, four sub-aortic and two were muscular. One patient also underwent pulmonary artery de-banding with pulmonary artery balloon angioplasty and other one patent ductus arteriosus ligation, concomitantly. For defect closure, we used ventricular septal defect occlusion device (MemoPart™, Lepu Medical Technology Company, China) through a 3-cm skin incision in the lower- third of the sternum. The device sizes ranged from 5 to 8 mm (mean 6.9+-1.8 mm) and all patients except for two required symmetrical devices. Results: All patients underwent device closure successfully. The procedural duration ranged between 32 and 52 min. None of the patients required cardiopulmonary bypass. The mean ventilation time and intensive care unit stay was 3 and 24 h, respectively. None of the patients required inotropic support or blood transfusions. Moreover, no patients developed any arrhythmias including heart block. The average length of hospital stay was 4.4 days. At the latest follow up, there were no residual shunts, conduction disturbances, device dislodgement or major aortic or tricuspid valve complications seen in any patients. There was no mortality. Conclusions: Perventricular device closure of ventricular septal defects is a less invasive, extremely safe and effective method in children. It is associated with very fast recovery, shorter hospitalization time and better cosmetic incision. Moreover, it avoids cardiopulmonary bypass. The modifications and refinements in the design, material and implantation techniques will help in expanding the indications and prevent complications in the long-term.

Unwitnessed lithium ion disc battery ingestion: case report and review of best practice management of an increasing clinical concern

Minimally Invasive Experiences on Perventricular Device Closure of Ventricular Septal Defects in Children

Minimally Invasive Perventricular Device Closure of Perimembranous Ventricular Septal Defect Without Cardiopulmonary Bypass: Multicenter Experience and Mid-Term Follow-Up

[Transesophageal Echocardiography-Guided Hybrid Therapy for Ventricular Septal Defects in Children].

Preparation Animal Model of Intracristal and Membranous Ventricular Septal Defects

Animal models of intracristal and membranous ventricular septal defect

Bipolar Electroporation Across the Interventricular Septum: Electrophysiological, Imaging, and Histopathological Characteristics

Perventricular device closure of the ventricular septal defects in children-first experience in the United Arab Emirates

In Vivo Cavitation-Based Aberration Correction of Histotripsy in Porcine Liver

Studies on the relationship between Besnoitia of blue wildebeest and impala, and Besnoitia besnoiti of cattle.

Intravenous infusion of cardiac progenitor cells in animal models of single ventricular physiology

Histotripsy: A Method for Mechanical Tissue Ablation with Ultrasound

Percutaneous epicardial pacing in infants using direct visualization: A feasibility animal study

Insights from in vivo preclinical cancer studies with histotripsy

Ultrasound imaging guided precision histotripsy: Effects of pulse settings on ablation properties in rat brain

The art of histotripsy: a focused ultrasound application that has the potential to treat from head to toe!

Simultaneous Transcatheter Closure of a Ventricular Septal Defect and Pulmonary Valvuloplasty: A Case Report

Ablating Myocardium Using Nanosecond Pulsed Electric Fields: Preclinical Assessment of Feasibility, Safety, and Durability

Pulsed Field Ablation of the Porcine Ventricle Using a Focal Lattice-Tip Catheter

High-intensity ultrasound catheter ablation achieves deep mid-myocardial lesions in vivo

Percutaneous Intramyocardial Septal Radiofrequency Ablation for Interventricular Septal Reduction: An Ovine Model with 1-Year Outcomes